Sodium-glucose cotransporter 2 (SGLT2) inhibitors with dipeptidyl peptidase-4 (DPP-4) inhibitors in elderly individuals with type 2 diabetes. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.